BlackRock Inc. Buys New Position in National Health Investors, Inc. $NHI

Key Points

• BlackRock acquired 8.73 million shares of National Health Investors in the second quarter, worth approximately $666 million, giving it an 18.02% stake. Institutional investors collectively own 62.51% of the REIT.
• Analysts lowered several price targets, but the stock retains a “Moderate Buy” consensus with an average target of $83.86, compared with a recent price of $73.59.
• National Health Investors reported quarterly revenue of $121.32 million and EPS of $1.19, while maintaining a quarterly dividend of $0.92 per share, equivalent to a 5.0% annualized yield.

BlackRock Inc. bought a new position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 8,733,237 shares of the real estate investment trust's stock, valued at approximately $665,997,000. BlackRock Inc. owned 18.02% of National Health Investors as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. International Assets Investment Management LLC bought a new position in shares of National Health Investors during the 4th quarter valued at about $27,000. EverSource Wealth Advisors LLC raised its holdings in shares of National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust's stock worth $28,000 after purchasing an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new stake in National Health Investors during the fourth quarter worth approximately $33,000. Advisory Services Network LLC bought a new stake in National Health Investors during the third quarter worth approximately $65,000. Finally, Triumph Capital Management acquired a new position in National Health Investors in the third quarter worth approximately $66,000. 62.51% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have issued reports on NHI shares. BMO Capital Markets dropped their price target on National Health Investors from $90.00 to $80.00 and set an "outperform" rating on the stock in a report on Monday, June 15th. Zacks Research cut National Health Investors from a "hold" rating to a "strong sell" rating in a report on Thursday, June 25th. Wells Fargo & Company cut their target price on National Health Investors from $84.00 to $79.00 and set an "equal weight" rating on the stock in a research report on Monday, June 1st. Weiss Ratings downgraded National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a report on Friday, June 12th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on National Health Investors from $85.00 to $80.00 and set a "hold" rating for the company in a research report on Thursday, June 25th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $83.86.

Insider Transactions at National Health Investors

In related news, CEO D. Eric Mendelsohn purchased 1,500 shares of National Health Investors stock in a transaction dated Friday, June 5th. The stock was acquired at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares of the company's stock, valued at $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert A. Mccabe, Jr. purchased 890 shares of the firm's stock in a transaction that occurred on Monday, June 15th. The shares were bought at an average price of $71.65 per share, with a total value of $63,768.50. Following the completion of the acquisition, the director owned 44,159 shares of the company's stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 2.70% of the company's stock.

National Health Investors Trading Up 0.3%

National Health Investors stock opened at $73.59 on Monday. National Health Investors, Inc. has a 52 week low of $67.94 and a 52 week high of $91.38. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The firm has a market capitalization of $3.61 billion, a price-to-earnings ratio of 21.27, a P/E/G ratio of 3.36 and a beta of 0.51. The company has a 50 day moving average price of $75.48 and a 200 day moving average price of $79.09.

National Health Investors (NYSE:NHI - Get Free Report) last released its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The company had revenue of $121.32 million during the quarter. During the same quarter in the previous year, the company earned $1.22 EPS. National Health Investors's revenue for the quarter was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Research analysts forecast that National Health Investors, Inc. will post 4.78 EPS for the current year.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.0%. National Health Investors's dividend payout ratio (DPR) is presently 108.67%.

National Health Investors Company Profile

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source